Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2009
12/30/2009EP2137171A2 Synthesis of chirally purified substituted benzothiazole diamines
12/30/2009EP2137170A1 Desferrithiocin polyether analogues
12/30/2009EP1711481B1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
12/30/2009EP1501812B1 Pna monomer and precursor
12/30/2009CN101613325A Process for producing 5-hydroxymethylthiazole
12/30/2009CN100575330C Novel compounds
12/30/2009CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
12/30/2009CA2728511A1 Sulfonamide compounds or salts thereof
12/30/2009CA2727340A1 Carboxylic acid compound
12/30/2009CA2727078A1 Sulfoximinamide compounds for combating animal pests
12/29/2009US7638648 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
12/29/2009US7638638 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents
12/29/2009US7638637 Orally available sphingosine 1-phosphate receptor agonists and antagonists
12/29/2009US7638540 Benzofuran compound and medicinal composition containing the same
12/29/2009US7638539 5-(4-{2-[5-methyl-2-(4-trifluoromethyl-phenyl)-thiazol -4-yl]-ethoxy}-phenyl)-3H-[1,3,4] oxadiazol-2-one; treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization such as multiple scleroses
12/29/2009US7638536 N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]-3-fluoro-4-hydroxybenzamide; nonpeptide c-mpl ligand; low immunogenicity; proliferate human c-mpl-Ba/F3 cells; increase platelets by promoting the formation of megakaryocytic colonies; orally
12/29/2009US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors
12/29/2009CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/29/2009CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors
12/29/2009CA2347763C Method of lithiating five-membered heterocycles
12/24/2009US20090318711 Non-Covalent Inhibitors of AmpC ß-Lactamase
12/24/2009US20090318651 Heterocyclic compound and heterocyclic polymers
12/24/2009US20090318513 Compounds exhibiting thrombopoietin receptor agonism
12/24/2009US20090318495 Ethenyl carboxamide derivatives useful as microbiocides
12/24/2009US20090318481 Potentiators Of Glutamate Receptors
12/24/2009US20090318389 Agonists of the sphingosine-1 phosphate receptor
12/24/2009US20090314990 Novel triphenylamine derivatives useful as fluorophores in biology, in particular for two-photon microscopy
12/23/2009WO2009155001A2 Wnt protein signalling inhibitors
12/23/2009WO2009154014A1 External composition
12/23/2009WO2009153238A1 Aminothiazoline compounds for combating insects, arachnids and nematodes
12/23/2009WO2009153226A1 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/23/2009WO2009153180A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009WO2009152735A1 Histone deacetylase inhibitors and uses thereof
12/23/2009EP2135864A1 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/23/2009EP1951695B1 CATALYZED PROCESS OF MAKING C-5-SUBSTITUTED HETEROCYCLIC INHIBITORS OF 11ß-HYDROXY STEROID DEHYDROGENASE TYPE 1
12/23/2009EP1817309B1 Acetamide compounds as fungicides
12/23/2009EP1709037B1 Hiv protease inhibiting sulfonamides
12/23/2009EP1483251B1 C3-cyano epothilone derivatives
12/23/2009CN100572367C 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes
12/23/2009CA2728139A1 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/23/2009CA2726703A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/22/2009CA2445749C Dyeing agents for keratin fibers, containing n-heteroarylmethyl-m-phenylenediamine deritaves, as well as new n-heteroarylmethyl-m-phenylenediamine derivatives
12/22/2009CA2290744C Cyclic diamine compounds and medicine containing the same
12/17/2009WO2009152082A1 Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors
12/17/2009WO2009114950A8 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
12/17/2009WO2008109727A8 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
12/17/2009US20090312556 N-(2-aminiphenyl)-4-(5-((ethylamino)methyl)-1,2-thiazol-2-yl) benzamide and n-(2-aminophenyl)-4-(5-((isopropylamino)methyl)-1,2-thiazol-2-yl) benzamide as hdac inhibitors
12/17/2009US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
12/17/2009US20090312376 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases
12/17/2009US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009US20090312314 Heteroaromatic monoamides as orexinin receptor antagonists
12/17/2009US20090312303 Antidiabetic Bicyclic Compounds
12/17/2009US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
12/16/2009EP2133342A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof
12/16/2009EP2132189A1 Salts of a selective beta-2 andrenoceptor agonist
12/16/2009EP2132188A2 Substituted phenoxy n-alkylated thiazoledinedione as estrogen related receptor-alpha modulators
12/16/2009CN101605770A Salts 668
12/16/2009CN101605769A Thiazole compound (as ppard) ligand and pharmaceutical, cosmetic and health food comprised thereof
12/16/2009CN101602745A Synthetic method and application of N, N'-bis-[3-hydroxy-4-(2-benzothiazole)phenyl] carbamide
12/16/2009CN101602744A Preparation method of nitazoxanide
12/16/2009CN101602743A Photochromic thiazole hexatomic ring series-parallel asymmetric perfluoro-cyclopentene compound and preparation method and application thereof
12/16/2009CN100569770C 5-phenylthiazole derivatives and their use as PI3 kinase inhibitors
12/16/2009CN100569760C Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
12/15/2009US7632952 Benzothiazoles and the use thereof as medicaments
12/15/2009US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009US7632846 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
12/15/2009CA2482917C 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
12/15/2009CA2405621C Cephalosporin intermediates
12/15/2009CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof
12/10/2009WO2009148269A2 Benzofluoranthene derivative and an organic luminescent element employing the same
12/10/2009WO2009148163A1 Agent for contracting bladder detrusor muscle and relaxing urethral sphincter muscle
12/10/2009WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/10/2009WO2009101082A9 Substituted sulfonic acid amide compounds
12/10/2009WO2009015369A3 Isophthalamide derivatives inhibiting beta-secretase activity
12/10/2009US20090306155 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
12/10/2009US20090306127 Certain Chemical Entities, Compositions and Methods
12/10/2009US20090306112 Antiviral protease inhibitors
12/10/2009US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/10/2009US20090306073 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers
12/10/2009US20090306069 Azolidinone-vinyl fused-benzene derivatives
12/10/2009US20090306022 7-substituted tetracycline compounds
12/10/2009CA2758016A1 Novel modulators of protein kinase signaling
12/10/2009CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers
12/09/2009EP2130820A1 Antipruritics
12/09/2009EP2130534A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450
12/09/2009EP2129668A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
12/09/2009EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009EP1300401B1 Thiazole derivatives for use as antiinflammatories
12/09/2009EP1067109B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
12/09/2009CN101597268A Processing method of mother liquor of ainothiazoly loximate
12/09/2009CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009CN100567279C Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors
12/09/2009CN100567277C Production of N-containing pentabasic heteroaromatic formamidine and salts thereof
12/09/2009CN100567276C Tri(cyclo) substituted amide compounds
12/09/2009CN100567275C 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents
12/09/2009CN100567274C [E]-beta-farnesene analogue, preparing method and application of the same
12/09/2009CN100567269C 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
12/09/2009CN100567265C Organometallic complexes and organic electroluminescence device using the same
12/08/2009US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 337